Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/21364
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWeinberg, Laurence-
dc.contributor.authorIanno, Damian-
dc.contributor.authorChurilov, Leonid-
dc.contributor.authorMcguigan, Steven-
dc.contributor.authorMackley, Lois-
dc.contributor.authorBanting, Jonathan-
dc.contributor.authorShen, Shi Hong-
dc.contributor.authorRiedel, Bernhard-
dc.contributor.authorNikfarjam, Mehrdad-
dc.contributor.authorChristophi, Christopher-
dc.date2019-
dc.date.accessioned2019-08-12T05:00:01Z-
dc.date.available2019-08-12T05:00:01Z-
dc.date.issued2019-09-
dc.identifier.citationAnnals of medicine and surgery 2019; 45: 45-53-
dc.identifier.issn2049-0801-
dc.identifier.urihttp://ahro.austin.org.au/austinjspui/handle/1/21364-
dc.description.abstractThe effect a restrictive goal directed therapy (GDT) fluid protocol combined with an enhanced recovery after surgery (ERAS) programme on hospital stay for patients undergoing major liver resection is unknown. We conducted a multicentre randomized controlled pilot trial evaluating whether a patient-specific, surgery-specific intraoperative restrictive fluid optimization algorithm would improve duration of hospital stay and reduce perioperative fluid related complications. Forty-eight participants were enrolled. The median (IQR) length of hospital stay was 7.0 days (7.0:8.0) days in the restrictive fluid optimization algorithm group (Restrict group) vs. 8.0 days (6.0:10.0) in the conventional care group (Conventional group) (Incidence rate ratio 0.85; 95% Confidence Interval 0.71:1.1; p = 0.17). No statistically significant difference in expected number of complications per patient between groups was identified (IRR 0.85; 95%CI: 0.45-1.60; p = 0.60). Patients in the Restrict group had lower intraoperative fluid balances: 808 mL (571:1565) vs. 1345 mL (900:1983) (p = 0.04) and received a lower volume of fluid per kg/hour intraoperatively: 4.3 mL/kg/hr (2.6:5.8) vs. 6.0 mL/kg/hr (4.2:7.6); p = 0.03. No significant differences in the proportion of patients who received vasoactive drugs intraoperatively (p = 0.56) was observed. In high-volume hepatobiliary surgical units, the addition of a fluid restrictive intraoperative cardiac output-guided algorithm, combined with a standard ERAS protocol did not significantly reduce length of hospital stay or fluid related complications. Our findings are hypothesis-generating and a larger confirmatory study may be justified.-
dc.language.isoeng-
dc.subjectCardiac output-
dc.subjectComplications-
dc.subjectFluid therapy-
dc.subjectHemodynamics-
dc.subjectHepatectomy-
dc.subjectMonitoring-
dc.subjectSurgery-
dc.titleGoal directed fluid therapy for major liver resection: A multicentre randomized controlled trial.-
dc.typeJournal Article-
dc.identifier.journaltitleAnnals of medicine and surgery-
dc.identifier.affiliationDepartment of Anaesthesia, Austin Health, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationDepartment of Anesthesia, Peter MacCallum Cancer Hospital, Victoria, Australiaen
dc.identifier.affiliationStatistics and Decision Analysis Academic Platform, The Florey Institute of Neuroscience and Mental Health, Melbourne Brain Centre, Victoria, Australiaen
dc.identifier.affiliationDepartment of Medicine, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationDepartment of Surgery, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australiaen
dc.identifier.doi10.1016/j.amsu.2019.07.003-
dc.identifier.orcid0000-0001-7403-7680-
dc.identifier.orcid0000-0002-9807-6606-
dc.identifier.orcid0000-0003-4866-276X-
dc.identifier.pubmedid31360460-
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.